Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions

Baeken Chris; Anna-Katharine Brem; Martijn Arns; Andre R Brunoni; Igor Filipčić; Ganho-Ávila Ana; Berthold Langguth; Frank Padberg; Emmanuel Poulet; Fady Rachid; Alexander T Sack; Marie-Anne Vanderhasselt; Djamila Bennabi

doi:10.1097/YCO.0000000000000533

Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions

Baeken Chris
, Anna-Katharine Brem
, Martijn Arns
, Andre R Brunoni
, Igor Filipčić
, Ganho-Ávila Ana
, Berthold Langguth
, Frank Padberg
, Emmanuel Poulet
, Fady Rachid
, Alexander T Sack^*
, Marie-Anne Vanderhasselt
, Djamila Bennabi

^*Corresponding author for this work

Neuroplasticity, Synchrony & Cognition

Research output: Contribution to journal › (Systematic) Review article › peer-review

Abstract

PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.

RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.

SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.

Original language	English
Pages (from-to)	409–415
Number of pages	7
Journal	Current Opinion in Psychiatry
Volume	32
Issue number	5
Early online date	27 May 2019
DOIs	https://doi.org/10.1097/YCO.0000000000000533
Publication status	Published - Sept 2019

Keywords

BIPOLAR DEPRESSION
DEEP TMS
DOUBLE-BLIND
EFFICACY
MAJOR DEPRESSION
METAANALYSIS
NETWORK
RTMS
TMS TREATMENT
TREATMENT-RESISTANT DEPRESSION
depression
efficacy
repetitive transcranial magnetic stimulation

Access to Document

10.1097/YCO.0000000000000533Licence: CC BY-NC-ND

Cite this

Chris, B., Brem, A.-K., Arns, M., Brunoni, A. R., Filipčić, I., Ana, G.-Á., Langguth, B., Padberg, F., Poulet, E., Rachid, F., Sack, A. T., Vanderhasselt, M.-A., & Bennabi, D. (2019). Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions. Current Opinion in Psychiatry, 32(5), 409–415. https://doi.org/10.1097/YCO.0000000000000533

@article{d0f5741f942141388deae151ed21b564,

title = "Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions",

abstract = "PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.",

keywords = "BIPOLAR DEPRESSION, DEEP TMS, DOUBLE-BLIND, EFFICACY, MAJOR DEPRESSION, METAANALYSIS, NETWORK, RTMS, TMS TREATMENT, TREATMENT-RESISTANT DEPRESSION, depression, efficacy, repetitive transcranial magnetic stimulation",

author = "Baeken Chris and Anna-Katharine Brem and Martijn Arns and Brunoni, \{Andre R\} and Igor Filip{\v c}i{\'c} and Ganho-{\'A}vila Ana and Berthold Langguth and Frank Padberg and Emmanuel Poulet and Fady Rachid and Sack, \{Alexander T\} and Marie-Anne Vanderhasselt and Djamila Bennabi",

note = "Funding Information: The Center for Research in Neuropsychology and Cognitive Behavioral Intervention of the Faculty of Psychology and Educational Sciences of the University of Coimbra is supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Education and Science through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement [UID/PSI/01662/2013]. This work was also supported by the German Center for Brain Stimulation (GCBS) research consortium (grant number 01EE1403), funded by the Federal Ministry of Education and Research (BMBF). Funding Information: C.B., F.P., and E.P. are members of the European Scientific Advisory Board of Brainsway Inc., Jerusalem, Israel. F.P.{\textquoteright}s lab has received support with equipment from neuroConn GmbH, Ilmenau, Germany, and Mag\&-More GmbH and Brainsway Inc., Jerusalem, Israel. Research Institute Brainclinics received research funding from Brain Resource (Sydney, Australia) and neuroCare Group (Munich, Germany), and equipment support from Deymed, neuroConn, and Magventure. Publisher Copyright: {\textcopyright} 2019 Wolters Kluwer Health, Inc. All rights reserved.",

year = "2019",

month = sep,

doi = "10.1097/YCO.0000000000000533",

language = "English",

volume = "32",

pages = "409–415",

journal = "Current Opinion in Psychiatry",

issn = "0951-7367",

publisher = "Lippincott Williams \& Wilkins",

number = "5",

}

Chris, B, Brem, A-K, Arns, M, Brunoni, AR, Filipčić, I, Ana, G-Á, Langguth, B, Padberg, F, Poulet, E, Rachid, F, Sack, AT, Vanderhasselt, M-A & Bennabi, D 2019, 'Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions', Current Opinion in Psychiatry, vol. 32, no. 5, pp. 409–415. https://doi.org/10.1097/YCO.0000000000000533

TY - JOUR

T1 - Repetitive transcranial magnetic stimulation treatment for depressive disorders

T2 - current knowledge and future directions

AU - Chris, Baeken

AU - Brem, Anna-Katharine

AU - Arns, Martijn

AU - Brunoni, Andre R

AU - Filipčić, Igor

AU - Ana, Ganho-Ávila

AU - Langguth, Berthold

AU - Padberg, Frank

AU - Poulet, Emmanuel

AU - Rachid, Fady

AU - Sack, Alexander T

AU - Vanderhasselt, Marie-Anne

AU - Bennabi, Djamila

N1 - Funding Information: The Center for Research in Neuropsychology and Cognitive Behavioral Intervention of the Faculty of Psychology and Educational Sciences of the University of Coimbra is supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Education and Science through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement [UID/PSI/01662/2013]. This work was also supported by the German Center for Brain Stimulation (GCBS) research consortium (grant number 01EE1403), funded by the Federal Ministry of Education and Research (BMBF). Funding Information: C.B., F.P., and E.P. are members of the European Scientific Advisory Board of Brainsway Inc., Jerusalem, Israel. F.P.’s lab has received support with equipment from neuroConn GmbH, Ilmenau, Germany, and Mag&-More GmbH and Brainsway Inc., Jerusalem, Israel. Research Institute Brainclinics received research funding from Brain Resource (Sydney, Australia) and neuroCare Group (Munich, Germany), and equipment support from Deymed, neuroConn, and Magventure. Publisher Copyright: © 2019 Wolters Kluwer Health, Inc. All rights reserved.

PY - 2019/9

Y1 - 2019/9

N2 - PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.

AB - PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.

KW - BIPOLAR DEPRESSION

KW - DEEP TMS

KW - DOUBLE-BLIND

KW - EFFICACY

KW - MAJOR DEPRESSION

KW - METAANALYSIS

KW - NETWORK

KW - RTMS

KW - TMS TREATMENT

KW - TREATMENT-RESISTANT DEPRESSION

KW - depression

KW - efficacy

KW - repetitive transcranial magnetic stimulation

U2 - 10.1097/YCO.0000000000000533

DO - 10.1097/YCO.0000000000000533

M3 - (Systematic) Review article

C2 - 31145145

SN - 0951-7367

VL - 32

SP - 409

EP - 415

JO - Current Opinion in Psychiatry

JF - Current Opinion in Psychiatry

IS - 5

ER -

Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions

Abstract

Keywords

Access to Document

Fingerprint

Cite this